CymaBay Therapeutics to Present New Data Highlighting Selade

/PRNewswire/ -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other...

Related Keywords

United States , Austria , Vienna , Wien , Theresa Dolge , Kris Kowdley , Charles Mcwherter , Christopherl Bowlus , Marlynj Mayo , Johnm Vierling , Douglasw Selinger , Gideonm Hirschfield , Charlesa Mcwherter , Gideon Hirschfield , Hans Vitzthum , Marye Standen , Davide Jones , Yun Jung Choi , Andrease Kremer , Dariab Crittenden , Exchange Commission , Nasdaq , Linkedin , International Liver Congress , Drug Administration , European Medicines Agency , Cymabay Therapeutics Inc , Twitter , Lifesci Advisors , Cymabay Therapeutics , European Association , Chief Scientific Officer , Presentation Details , Cynthia Levy , Bay Therapeutics , Priority Medicines , Statements Any , Annual Report , Relations Contact , Sci Advisors ,